U.S. Markets open in 9 hrs 1 mins

Galectin Therapeutics, Inc. (GALT)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.91+0.03 (+1.60%)
At close: 4:00PM EDT
People also watch
Currency in USD

Valuation Measures

Market Cap (intraday) 566.95M
Enterprise Value 352.21M
Trailing P/E -3.12
Forward P/E 1-2.42
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.68

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profit Margin 0.00%
Operating Margin (ttm)0.00%
Management Effectiveness
Return on Assets (ttm)-88.27%
Return on Equity (ttm)-181.73%
Income Statement
Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -19.47M
Net Income Avi to Common (ttm)-19.53M
Diluted EPS (ttm)-0.61
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)9.13M
Total Cash Per Share (mrq)0.26
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.66
Book Value Per Share (mrq)-0.09
Cash Flow Statement
Operating Cash Flow (ttm)-17.17M
Levered Free Cash Flow (ttm)-10.8M

Trading Information

Stock Price History
Beta 3.11
52-Week Change 3-25.40%
S&P500 52-Week Change 316.52%
52 Week High 32.70
52 Week Low 30.49
50-Day Moving Average 31.76
200-Day Moving Average 31.80
Share Statistics
Avg Vol (3 month) 3123.83k
Avg Vol (10 day) 3155.6k
Shares Outstanding 535.05M
Float 28.04M
% Held by Insiders 122.19%
% Held by Institutions 118.06%
Shares Short 31.15M
Short Ratio 38.95
Short % of Float 34.19%
Shares Short (prior month) 31.3M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/6
Last Split Date 3Mar 23, 2012